REPROCELL EUROPE LIMITED
REPROCELL's scientists can test the effectiveness of potential new medicines, for diseases such as asthma and COPD.
Helping new medicines gain regulatory approval
Gaining regulatory approval to continue the development with clinical trials is a challenging but critical step in any drug discovery pipeline. Before a test article reaches this stage, researchers must generate preclinical data demonstrating safety and efficacy compared with compounds already on the market. Numerous laboratory models can be used to obtain this data, including cell culture assays, animal models, and human tissue testing.
Pharma company Arcede Pharma, a spin-out from Respiratorius AB (Lund, Sweden) used human tissue testing to generate preclinical efficacy data for their compound RCD405.2 Reprocell's testing services in human tissue helped to demonstrate the therapeutic value of RCD405 following a request from the Swedish Medical Products Agency.
Company details
- Industry:
- Life sciences
"These are crucial important results for RCD405 where, for the first time in the same model, we can compare with established bronchodilatory substances. Something that was also requested earlier at the scientific advisory meeting at the Swedish Medical Products Agency." Source: BioStock. Respiratorius’ RCD405 shows efficacy in preclinical study, 2021Johan Drott CEO Respiratorius